一种免疫信息学方法,用于开发针对病毒病毒的多表位子单元疫苗
Ashmad Kumar Nayak1, Aritra Chakraborty1, Sakshi Shukla1
1Department of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Madhya Pradesh India.
In silico pharmacology
|May 15, 2024
概括
这项研究使用计算方法设计了一种针对病毒的多表位子单元疫苗. 体疫苗结构显示出强烈免疫反应的潜力,表明它是一个有前途的候选人.
科学领域:
- * 生物信息学和疫苗学
- * 计算生物学 * 计算生物学
- * 病毒学 病毒学
背景情况:
- *病毒爆发需要快速开发有效的疫苗.
- * 传统的疫苗开发是耗时且资源密集的.
- * 体内方法为疫苗设计提供了更快,更具成本效益的替代方案.
研究的目的:
- * 设计和计算验证一种针对病毒的多表位子单元疫苗.
- * 预测疫苗构造的免疫性,过敏性和结构稳定性.
- * 评估疫苗与托尔类受体4 (TLR4) 的免疫激活相互作用.
主要方法:
- *从病毒病毒蛋白中选择T细胞和B细胞表位.
- *对抗原性,过敏原性和物理化学性质的体分析.
- *使用SOPMA和I-TASSER预测二次和3D结构.
- *分子对接和动力学模拟以评估疫苗与受体相互作用.
- * 计算免疫反应预测.
主要成果:
- *成功设计了一种多表位疫苗结构.
- *该结构表现出有利的物理化学特性和低过敏性.
- *分子对接和动力学模拟证实了与TLR4的稳定相互作用.
- * 计算免疫试验预测了针对的强有力的免疫反应.
结论:
- * 开发的in-silico多型疫苗结构是对麻疹的有力候选者.
- *计算方法为快速开发疫苗提供了可行的策略.
- *需要进一步的实验验证,以确认疗效.
更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.6K
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
